Study reveals challenges and risks for women using anabolic-androgenic steroids

A new study published in Drug and Alcohol Review has revealed critical insights into the challenges and risks faced by women who use anabolic-androgenic steroids (AAS).

CEB-01 by Cebiotex for Nerve Sheath Tumor: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Nerve Sheath Tumor.

June 20, 2024

ProMED, an early warning system on disease outbreaks, appears near collapse

The early warning disease network that alerted the world to the original SARS outbreak and the start of the Covid-19 pandemic appears to be in

August 3, 2023

Novel Turmeric Derivative Drug Shows Promise in Head and Neck Cancer

MONTREAL – An investigational drug derived from turmeric (Curcuma longa) appeared to have activity in patients being evaluated for head and neck cancer therapy, at

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.